top of page

Our Services

1

Research

Screening and research the market for potentially interesting projects and companies

​​

​

​

​

2

Preselection

Preselecting projects and companies that are important for the SCI community and have a high chance to be successful and/ or gamechanger

3

Company Check

Company Due Diligence including possible patents, registration etc for companies in the medical field

​

​

4

Network Access

SCInvest offers  privileged access to various outstanding hospitals, rehab centers and other important instiotutions in Europe and the world

5

Business Development

With many years of experience in business development, strategy, marketing and sales we help the companies to make their business a success. 

6

Ambassador

We are also open to become ambassors of the companies we work together. If possible we will also co-invest.

  • We become ambassadors for the SCI company 

  • We invest our time & money in selected companies

  • We have privileged access to various outstanding hospitals and rehab centers in Europe and the world

TWIICE 

 

Get the benefits of walking in real-life thanks to the most agile and lightweight powered exoskeleton.

 

​

TWIICE develops next-generation powered exoskeletons that restore walking ability for individuals with spinal cord injuries. As the smallest and lightest solution in the industry, their patented technology enables users to navigate real-world environments, including stairs and slopes up to 15 degrees.

​

Their innovative digital manufacturing process enables rapid feature development and a 5x reduction in manufacturing costs compared to industry average. Combined with their expertise in human-machine interaction and cognitive neuroscience, they've achieved remarkable improvements: 13x shorter learning time, 3x faster setup, and 3x more agility than industry standards.

​

The system's versatility is demonstrated through its adaptable design, supporting users between 1.60m and 1.90m in height, weighing up to 100kg, with spinal cord injuries at level C5 or below. A single device can accommodate multiple users, and their clinical validation is backed by partnerships with the Swiss Paraplegic Center and leading rehabilitation institutions.

​

With the recent Medicare/Medicaid decision to reimburse powered exoskeletons for eligible patients, a $16B market has opened in the US alone. The team, bringing 40 years of experience in rehabilitation robotics including PhDs in robotics and cognitive neuroscience, is well-positioned to capture this opportunity.

​

GBY

Go By Yourself

 

GBY SWISS has developed a new approach for the rehabilitation of people with reduced mobility, such as people suffering from paraplegia, multiple sclerosis and many more.

 

https://www.gby.swiss

GBY is revolutionizing the rehabilitation process for people suffering from paraplegia, stroke, multiple sclerosis, etc. thanks to a therapy encompassing the whole body. This unique vision seeks to activate the invalid limbs using the movements of the valid limbs, thereby facilitating the natural relearning of motor functions.

 

The company is currently raising CHF 1.5 million as part of a CHF 4 million financing round. This investment will support the next phase: obtaining scientific validation of the rehabilitation results we have seen so far, expanding its market in the EU and USA and developing therapy equipment. GBY has received support from the Swiss Paraplegic Foundation in Nottwil and more than 80 of these bikes (Go-Tryke Easy) have been sold, trikes that use the GBY therapy principle.

​

Investor Video 

​

Get further information

We are looking forward to send you further information or making a videoconference

© 2025 by SCInvest GmbH

bottom of page